Subclinical Atrial Fibrillation Home Monitoring in Hypertensive Patients
Recruiting
Observational Study
Asymptomatic Atrial Fibrillation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 499 (estimated)
- Sponsor
- Cardiovascular Research Center Rosario British Sanatorium · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Atrial fibrillation is a highly prevalent and incidental arrhythmia, often asymptomatic, and frequently detected incidentally or in association with a stroke. Subclinical atrial fibrillation increases cardioembolic risk, highlighting the need for timely diagnosis.
New wireless devices capable of recording heart rhythm, combined with innovative artificial intelligence tools, could be useful in the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\. Hypertensive patients of both sexes over 75 years of age. 2. Hypertensive patients between 65 and 75 years of age are associated with one of the following risk factors:
1. Obesity
2. Type 2 diabetes
3. Obstructive sleep apnea syndrome
4. Electrocardiogram showing …
Contacts